Lupin Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹7,474.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.29 per cent from ₹7,167.52 crore. This corresponds to a year-on-year *(YoY) growth of 31.89 per cent.
Operating Profit
Operating Profit stands at ₹2,354.24 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.28 per cent from ₹1,835.28 crore. This corresponds to a year-on-year *(YoY) growth of 78.19 per cent.
PBDT
PBDT stands at ₹2,374.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.42 per cent from ₹1,835.00 crore. This corresponds to a year-on-year *(YoY) growth of 84.23 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1,928.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 26.67 per cent from ₹1,522.04 crore. This corresponds to a year-on-year *(YoY) growth of 115.22 per cent.
Net Profit
Net Profit stands at ₹1,468.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.41 per cent from ₹1,180.51 crore. This represents a 87.72 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Lupin Ltd News
Lupin Ltd Earnings
- YOY
- QOQ
Lupin Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Lupin Ltd Research Reports
Lupin Ltd Financial Reports
Lupin Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Lupin | 0.11% | 3.91% | 10.12% | 8.55% | 14.26% | 30.28% |
| Torrent Pharma. | 1.66% | 5.81% | 10.30% | 20.53% | 24.49% | 47.07% |
| Cipla | 0.55% | 0.05% | 5.83% | 19.01% | -0.62% | -2.33% |
| Zydus Lifesci. | 1.48% | 6.40% | 5.81% | 29.69% | 30.73% | 19.60% |
| Dr Reddy's Labs | 0.50% | 1.06% | 7.23% | 12.22% | 12.49% | 7.16% |
| Mankind Pharma | -0.54% | 1.17% | 5.25% | 22.51% | 14.40% | -0.35% |
| Aurobindo Pharma | 0.28% | 1.68% | 9.69% | 18.42% | 32.36% | 38.67% |
Company Info
Company Information
Chairman (Non-Executive) : M D Gupta
Managing Director : Nilesh Deshbandhu Gupta.
Director & Chief Executive Officer : Vinita Gupta
Company Sec. & Compli. Officer : R V Satam
Independent Director : Jean-Luc Belingard
Director & Group CFO : Ramesh Swaminathan
Independent Director : Mark D McDade
Independent Director : K B S Anand
Independent Director : Jeffrey Kindler
Independent Director : Alfonso Zulueta
Independent Director : Punita Lal